Position in DNLI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$202,694
-$563,089 QoQ
Shares Held
10,557
-77.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Headlands Technologies LLC holds $60,689,199 across 67 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,545 | $6,575,229 | |
| 2 | RPRX |
Royalty Pharma plc
|
90,729 | $5,087,175 | |
| 3 | INSM |
INSMED Inc
|
40,855 | $4,355,960 | |
| 4 | BNTX |
BioNTech SE
|
27,087 | $2,520,445 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
72,335 | $2,451,433 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
248,550 | $2,176,055 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
246,252 | $1,933,078 | |
| 8 | NVAX |
Novavax Inc
|
190,547 | $1,794,952 |
All Filings in DNLI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $202,694 | 10,557 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $765,783 | 46,383 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $25,839 | 1,847 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $88,133 | 4,295 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||